The Double-Edged Sword Property of Mesenchymal Stem Cell-Derived Exosomal microRNAs in Colorectal Cancer

Hongliang Yao1, Caihua Sun1, Chengjun Wang1

  • 1The Second Department of General Surgery, Hengshui People's Hospital, Hengshui, Hebei Province, China.

Insights

Mesenchymal stem cells (MSCs)-derived exosomal microRNAs show paradoxical effects in colorectal cancer (CRC). This review explores their dual role in CRC progression and potential as a therapeutic strategy for cancer treatment.

Area of Science:

  • Oncology
  • Stem Cell Biology
  • Molecular Biology

Background:

  • Mesenchymal stem cells (MSCs) show promise in cancer therapy due to immunomodulatory and regenerative properties.
  • MSCs exhibit a dual role in colorectal cancer (CRC), with some studies reporting inhibitory effects and others indicating tumor-promoting impacts.
  • Exosomal microRNAs (Exo-miRs) from MSCs (MSCs-Exo-miRs) are implicated in this paradoxical activity.

Purpose of the Study:

  • To investigate the role of MSCs-Exo-miRs in colorectal cancer (CRC) progression.
  • To evaluate the therapeutic potential of MSCs-Exo-miRs for CRC treatment.

Main Methods:

  • Literature review of studies investigating MSCs-Exo-miRs in CRC.
  • Analysis of reported effects of MSCs-Exo-miRs on cancer cell proliferation, migration, and infiltration.
  • Evaluation of therapeutic strategies involving MSCs-Exo-miRs for CRC.

Main Results:

  • MSCs-Exo-miRs can either suppress or promote CRC progression, depending on the specific microRNAs and context.
  • Certain MSCs-Exo-miRs demonstrate inhibitory effects on CRC cell proliferation and metastasis.
  • Other MSCs-Exo-miRs have been shown to enhance CRC growth and invasion.

Conclusions:

  • MSCs-Exo-miRs represent a critical factor mediating the dual effects of MSCs in CRC.
  • Understanding the specific functions of MSCs-Exo-miRs is crucial for developing effective cell-based therapies for CRC.
  • Targeting specific MSCs-Exo-miRs holds potential for novel therapeutic interventions against colorectal cancer.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K